HHS, FDA open to importing prescription drugs

Determined to explore more avenues to curb price hikes, the administration is signaling that it is willing to consider what the industry regards as something of a nuclear option.

By Rachel Bluth, Kaiser Health News | August 01, 2018 at 11:39 AM

exploring the importation of prescription drugs high domestic prices also endorsed opposed the idea getting away with murder tweeted at companies Related: Few voters believe Trump will lower drug prices price hike $750 first time produced two reports tepid support among the companies KHN's coverage of prescription drug development, costs and pricing is supported in part by the Laura and John Arnold Foundation. Kaiser Health News (KHN) is a national health policy news service. It is an editorially independent program of the Henry J. Kaiser Family Foundation which is not affiliated with Kaiser Permanente.

NOT FOR REPRINT

1 House committee proposes plan to cut back on federal employee pensions

2 Understanding Subrogation: Best Practices for Benefits Advisors and TPAs

3 9 in 10 Americans have put off health checkups, life-saving screenings

4 Pharmacist group tells Elon Musk's team to probe pharmacy benefit managers

5 Sutter Health to pay $228.5M to settle antitrust lawsuit

Insurance
BenefitsPRO Broker Expo 2025
May 06, 2025 - Boston

The premier educational and networking event for employee benefits brokers and agents.
More Information
Workers' Compensation Risk Management Award for Excellence Nominations
May 05, 2025 - Nomination Deadline

The 2025 Workers Comp Risk Management Award for Excellence honors outstanding loss control, safety and return-to-work programs.
More Information
Consulting
Consulting Top Consultants 2025
June 26, 2025 - New York

Consulting Magazine identifies consultants that have the biggest impact on their clients, firms and the profession.
More Information